GLP-1 Agents Showed Broader Risks, Rewards in 2025

(MedPage Today) — In January 2025, we reported about an observational study of nearly 2 million U.S. military veterans that showed a broad spectrum of possible risks and benefits associated with GLP-1 receptor agonists. In this report, we follow…